Yesterday a court ruled that the South African running sensation Caster Semenya must take medication to lower her level of testosterone to compete in certain women only running events such as the 400 and 800 meters.
Some are calling the ruling discrimination against a certain athlete or against transgener or intersex athletes. Some say the ruling is necessary to keep the sport fair. It’s a worthy debate.
What I find particularly useful about the debate is what it tells us about how our colleagues in the science community are thinking.